Placental vascular pathology findings and pathways to preterm delivery

American Journal of Epidemiology

Volumn 170, Issue 2, 2009, Pages 148-158

  Holzman, C ^a   Kelly, R ^b   Senagore, P ^b   Wang, J ^b   Tian, Y ^b   Rahbar, M H ^b   Chung, H ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Blood vessels; Placenta; Premature birth

Indexed keywords

BLOOD; COHORT ANALYSIS; LESION; MULTIVARIATE ANALYSIS; PATHOLOGY; PREGNANCY; REGRESSION ANALYSIS;

ADULT; ARTICLE; BLOOD FLOW; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ETHNIC AND RACIAL GROUPS; EVALUATION; FEMALE; GESTATIONAL AGE; HEALTH INSURANCE; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CARE; MOTHER FETUS RELATIONSHIP; PATIENT INFORMATION; PATIENT SELECTION; PLACENTA CIRCULATION; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; RISK; VASCULAR DISEASE;

ADULT; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; ODDS RATIO; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

MICHIGAN; NORTH AMERICA; UNITED STATES;

EID: 67651123145     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp131     Document Type: Article

References (33)

1. Beebe LA, Cowan LD, Altshuler G. The epidemiology of placental features: associations with gestational age and neonatal outcome. Obstet Gynecol. 1996;87(5):771-778.
2. Arias F, Rodriquez L, Rayne SC, et al. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol. 1993;168(2):585-591.
3. Kim YM, Bujold E, Chaiworapongsa T, et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2003;189(4):1063-1069.
4. Kim YM, Chaiworapongsa T, Gomez R, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol. 2002;187(5):1137-1142.
5. Salafia CM, Pezzullo JC, López-Zeno JA, et al. Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol. 1995;173(4):1097-1105.
6. Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195(6):1557-1563.
7. Ananth CV, Savitz DA, Luther ER, et al. Preeclampsia and preterm birth subtypes in Nova Scotia, 1986 to 1992. Am J Perinatol. 1997;14(1):17-23.
8. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350(7):672-683.
9. Chaiworapongsa T, Espinoza J, Gotsch F, et al. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med. 2008;21(1): 25-40.
10. Chaiworapongsa T, Yoshimatsu J, Espinoza J, et al. Evidence of in vivo generation of thrombin in patients with smallfor- gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med. 2002;11(6):362-367.
11. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008; 21(1):9-23.
12. Shibata E, Rajakumar A, Powers RW, et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005;90(8):4895-4903.
13. Signore C, Mills JL, Qian C, et al. Circulating angiogenic factors and placental abruption. Obstet Gynecol. 2006;108(2): 338-344.
14. Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004;89(2): 770-775.
15. Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol. 2001;185(5):1059-1063.
16. Goldenberg RL, Andrews WW, Faye-Petersen O, et al. The Alabama Preterm Birth Project: placental histology in recurrent spontaneous and indicated preterm birth. Am J Obstet Gynecol. 2006;195(2):792-796.
17. Ananth CV, Getahun D, Peltier MR, et al. Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. Obstet Gynecol. 2006;107(4): 785-792.
18. Villar J, Carroli G, Wojdyla D, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol. 2006;194(4): 921-931.
19. Salafia CM, Ernst LM, Pezzullo JC, et al. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol. 1995;12(2):106-110.
20. Ghidini A, Salafia CM, Pezzullo JC. Placental vascular lesions and likelihood of diagnosis of preeclampsia. Obstet Gynecol. 1997;90(4):542-545.
21. Corrêa RR, Gilio DB, Cavellani CL, et al. Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet. 2008;277(3):201-206.
22. Kramer MS, Chen MF, Roy I, et al. Intra- and interobserver agreement and statistical clustering of placental histopathologic features relevant to preterm birth. Am J Obstet Gynecol. 2006;195(6):1674-1679.
23. Salafia CM, Pezzullo JC, Ghidini A, et al. Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. Placenta. 1998;19(1):67-72.
24. Redline RW, Boyd T, Campbell V, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7(3):237-249.
25. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol. 1995;26(1):80-85.
26. Sander CM, Gilliland D, Akers C, et al. Livebirths with placental hemorrhagic endovasculitis: interlesional relationships and perinatal outcomes. Arch Pathol Lab Med. 2002;126(2): 157-164.
27. Holzman C, Bullen B, Fisher R, et al. Pregnancy outcomes and community health: the POUCH study of preterm delivery. Paediatr Perinat Epidemiol. 2001;15(suppl 2):136-158.
28. Waller DK, Lustig LS, Cunningham GC, et al. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol. 1996;88(5): 816-822.
29. Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta. 2008;29(suppl A):S86-S91.
30. Dowling NF, Austin H, Dilley A, et al. The epidemiology of venous thromboembolisminCaucasians andAfrican-Americans: the GATE Study. J Thromb Haemost. 2003;1(1):80-87.
31. Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7(5):443-452.
32. Ogunyemi D, Murillo M, Jackson U, et al. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003; 13(2):102-109.
33. Salafia CM, Minior VK, Pezzullo JC, et al. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol. 1995;173(4):1049- 1057.